Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine

Details for Australian Patent Application No. 2002355205 (hide)

Owner Cadila Healthcare Ltd.

Inventors Lohray, Braj Bhushan; Lohray, Vidya Bhushan; Barot, Vijay Kumar; Raval, Saurin Khimshankar; Raval, Preeti Saurin; Basu, Sujay

Agent LESICAR PERRIN

Pub. Number AU-B-2002355205

PCT Number PCT/IN02/00155

PCT Pub. Number WO2003/009841

Priority 711/MUM/2001 26.07.01 IN

Filing date 25 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 18 November 2004

International Classifications

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 003/06 Drugs for disorders of the metabolism

C07D 207/325 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/333 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 407/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 711/MUM/2001 26.07.01 IN

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002355205

18 November 2004 Application Accepted

  Published as AU-B-2002355205

17 March 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002355206-IDENTIFICATION OF SPECIFIC TUMOUR ANTIGENS BY MEANS OF THE SELECTION OF CDNA LIBRARIES WITH SERA AND THE USE OF SAID ANTIGENS IN DIAGNOSTIC IMAGING TECHNIQUES

2002355204-Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics